Feasibility of single time point dosimetry during 177Lu-PSMA-617 treatments of prostate cancer
Introduction: Standard dosimetry methods for radionuclide therapies re- quire imaging at multiple time points post injection. An alternative method has been presented in the literature that uses previously acquired pharma- cokinetic data to create so-called dose factors. Multiplying the dose factors with an activity concentration (Bq/ml) taken from a single time point mea- surement results in an e
